# Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology

> **NCT01596452** · — · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 31 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01596452
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2013-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596452, "Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01596452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*